Companies have varying degrees of maturity and future prospects, and each of these in addition to other particularities influence how much the business really is worth. When it comes to startups and innovation businesses the challenges are even greater, since many businesses still do not have a satisfactory cash flow, while exposing million-dollar projections
In this way, Brasbiotec has specialized in the valuation process of biotechnology businesses, mainly associated with companies in the early stages of development, where there are few resources and investments, often with only one product not yet validated in the market, and with high expectations growth and economic gains.
For this, the company developed its own methodology that allows the integration of value vectors, providing a more efficient valuation when compared to traditional valuation methodologies.
If you have interest or questions about our methodology and valuation process, please contact us.